168 related articles for article (PubMed ID: 23542713)
1. Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes.
Kotake D; Hirasawa N
Eur J Pharmacol; 2013 May; 707(1-3):95-103. PubMed ID: 23542713
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
4. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
Sotiropoulos KB; Clermont A; Yasuda Y; Rask-Madsen C; Mastumoto M; Takahashi J; Della Vecchia K; Kondo T; Aiello LP; King GL
FASEB J; 2006 Jun; 20(8):1203-5. PubMed ID: 16672634
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: a comparison with dexamethasone.
Tchoukalova YD; Hausman DB; Dean RG; Hausman GJ
Obes Res; 2000 Dec; 8(9):664-72. PubMed ID: 11225715
[TBL] [Abstract][Full Text] [Related]
7. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
8. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
9. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
Elstner E; Müller C; Koshizuka K; Williamson EA; Park D; Asou H; Shintaku P; Said JW; Heber D; Koeffler HP
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8806-11. PubMed ID: 9671760
[TBL] [Abstract][Full Text] [Related]
10. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
[TBL] [Abstract][Full Text] [Related]
11. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
12. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
14. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
Yasugi E; Horiuchi A; Uemura I; Okuma E; Nakatsu M; Saeki K; Kamisaka Y; Kagechika H; Yasuda K; Yuo A
Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735
[TBL] [Abstract][Full Text] [Related]
16. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
17. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
Skurk T; Birgel M; Lee YM; Hauner H
Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
[TBL] [Abstract][Full Text] [Related]
18. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
Chintalgattu V; Harris GS; Akula SM; Katwa LC
Cardiovasc Res; 2007 Apr; 74(1):140-50. PubMed ID: 17320065
[TBL] [Abstract][Full Text] [Related]
19. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
Xiao Y; Yuan T; Yao W; Liao K
FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
